Medtronic plc
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2022 | 2023 | 2024 | 2025 | 2026 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 31.69B | 31.23B | 32.36B | 33.54B | 36.36B | 8.4% | |
| Cost of Revenue | (10.14B) | (10.72B) | (11.22B) | (11.63B) | (12.72B) | 9.4% | |
Gross Profit | 21.54B | 20.51B | 21.15B | 21.91B | 23.64B | 7.9% | |
| Operating Expenses | |||||||
| Research & Development | (2.75B) | (2.70B) | (2.73B) | (2.73B) | (2.87B) | 5.2% | |
| Selling, General & Administrative | (10.29B) | (10.41B) | (10.74B) | (10.85B) | (11.78B) | 8.6% | |
| Depreciation & Amortization | (2.71B) | (2.70B) | (2.65B) | (2.86B) | — | -100.0% | |
Operating Income (EBIT) | 5.75B | 5.49B | 5.14B | 5.96B | 6.47B | 8.6% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (553.00M) | (636.00M) | (719.00M) | (729.00M) | (715.00M) | -1.9% | |
| Other Income/Expenses (Net) | -235.00M | -121.00M | -307.00M | -327.00M | -331.00M | 1.2% | |
Income Before Tax | 5.52B | 5.36B | 4.84B | 5.63B | 6.14B | 9.0% | |
| Income Tax Expense | (456.00M) | (1.58B) | (1.13B) | (936.00M) | (1.30B) | 38.8% | |
Net Income | 5.04B | 3.76B | 3.68B | 4.66B | 4.80B | 3.0% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $4 | $3 | $3 | $4 | $4 | 3.3% | |
| Weighted Avg Shares Outstanding | 1.34B | 1.33B | 1.33B | 1.29B | 1.28B | -0.3% | |
| Weighted Avg Shares Outstanding (Diluted) | 1.35B | 1.33B | 1.33B | 1.29B | 1.29B | -0.1% | |
EBITDA | 8.78B | 8.70B | 8.20B | 9.22B | 6.85B | -25.7% |
Explore MDT
MDT in the Healthcare
Large Cap